STOCK TITAN

Dror Ortho-Design Financials

DROR
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Dror Ortho-Design (DROR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Dror Ortho-Design passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.81x

For every $1 of reported earnings, Dror Ortho-Design generates $0.81 in operating cash flow (-$2.1M OCF vs -$2.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
N/A
EBITDA
-$2.2M
YoY+57.5%

Dror Ortho-Design's EBITDA was -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 57.5% from the prior year.

Net Income
-$2.5M
YoY+55.9%

Dror Ortho-Design reported -$2.5M in net income in fiscal year 2025. This represents an increase of 55.9% from the prior year.

EPS (Diluted)
$0.00
YoY+100.0%

Dror Ortho-Design earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$2.1M
YoY+25.6%

Dror Ortho-Design generated -$2.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 25.6% from the prior year.

Cash & Debt
$229K
YoY-58.4%
5Y CAGR-6.6%

Dror Ortho-Design held $229K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
957M
YoY+0.0%
5Y CAGR+36.5%

Dror Ortho-Design had 957M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A

Capital Allocation

R&D Spending
$816K
YoY-47.0%

Dror Ortho-Design invested $816K in research and development in fiscal year 2025. This represents a decrease of 47.0% from the prior year.

Share Buybacks
N/A
Capital Expenditures
$966
YoY-96.3%

Dror Ortho-Design invested $966 in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 96.3% from the prior year.

DROR Income Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A $151K-53.3% $324K+35.3% $240K N/A $451K+15.9% $389K+4.2% $374K
SG&A Expenses N/A $318K-18.7% $391K+24.8% $314K N/A $308K-7.7% $333K-13.6% $386K
Operating Income N/A -$470K+35.8% -$732K-26.9% -$576K N/A -$1.3M+13.0% -$1.5M-15.5% -$1.3M
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A -$654K+13.9% -$759K-31.8% -$576K N/A -$1.8M-21.2% -$1.5M-15.2% -$1.3M
EPS (Diluted) N/A $0.00 $0.00 $0.00 N/A $0.00 $0.00 $0.00

DROR Balance Sheet

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Total Assets $259K-4.5% $271K+104.5% $133K-70.1% $443K-33.1% $663K-47.7% $1.3M-34.0% $1.9M-28.1% $2.7M
Current Assets $239K-4.8% $251K+126.1% $111K-73.6% $420K-34.2% $639K-48.6% $1.2M-34.4% $1.9M-28.6% $2.7M
Cash & Equivalents $229K-4.9% $240K+272.8% $64K-81.6% $350K-36.3% $549K-51.9% $1.1M-37.7% $1.8M-28.1% $2.6M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $3.1M+21.0% $2.6M+44.1% $1.8M+31.7% $1.4M+32.4% $1.0M+15.4% $893K+239.6% $263K-7.2% $283K
Current Liabilities $3.0M+22.1% $2.4M+47.7% $1.6M+33.2% $1.2M+35.7% $907K+2.1% $888K+244.2% $258K-7.3% $278K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$2.9M-24.0% -$2.3M-39.3% -$1.7M-80.7% -$921K-150.3% -$368K-198.3% $374K-77.4% $1.7M-30.6% $2.4M
Retained Earnings -$22.1M-2.6% -$21.5M-3.1% -$20.8M0.0% -$20.8M-6.8% -$19.5M-6.2% -$18.4M-11.0% -$16.5M-10.0% -$15.0M

DROR Cash Flow Statement

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Operating Cash Flow -$649K-53.0% -$424K+12.6% -$485K+2.8% -$500K+11.3% -$563K+18.5% -$691K+2.2% -$706K+9.6% -$781K
Capital Expenditures N/A N/A N/A N/A $0 $0-100.0% $9K-45.6% $17K
Free Cash Flow N/A N/A N/A N/A -$563K+18.5% -$691K+3.4% -$716K+10.3% -$798K
Investing Cash Flow N/A N/A N/A N/A $0 $0+100.0% -$9K+45.6% -$17K
Financing Cash Flow $650K+8.3% $600K+200.0% $200K-33.3% $300K N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

DROR Financial Ratios

Metric Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24 Q1'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A -487.9%-397.0pp -90.9%-36.1pp -54.7%
Return on Assets N/A -241.0%+331.6pp -572.6%-442.6pp -130.0% N/A -144.1%-65.7pp -78.4%-29.5pp -48.9%
Current Ratio 0.08-0.0 0.10+0.0 0.07-0.3 0.34-0.4 0.70-0.7 1.40-5.9 7.35-2.2 9.55
Debt-to-Equity -1.09+0.0 -1.12-0.0 -1.08+0.4 -1.48+1.3 -2.80-5.2 2.38+2.2 0.16+0.0 0.12
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$2.9M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

No, Dror Ortho-Design (DROR) reported a net income of -$2.5M in fiscal year 2025.

Dror Ortho-Design (DROR) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Dror Ortho-Design (DROR) had EBITDA of -$2.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Dror Ortho-Design (DROR) generated -$2.1M in free cash flow during fiscal year 2025. This represents a 25.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Dror Ortho-Design (DROR) generated -$2.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Dror Ortho-Design (DROR) had $259K in total assets as of fiscal year 2025, including both current and long-term assets.

Dror Ortho-Design (DROR) invested $966 in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Dror Ortho-Design (DROR) invested $816K in research and development during fiscal year 2025.

Dror Ortho-Design (DROR) had 957M shares outstanding as of fiscal year 2025.

Dror Ortho-Design (DROR) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Dror Ortho-Design (DROR) had a debt-to-equity ratio of -1.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Dror Ortho-Design (DROR) had a return on assets of -982.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Dror Ortho-Design (DROR) had $229K in cash against an annual operating cash burn of $2.1M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Dror Ortho-Design (DROR) has negative shareholder equity of -$2.9M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Dror Ortho-Design (DROR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Dror Ortho-Design (DROR) has an earnings quality ratio of 0.81x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top